Glycogenosis type II is a lysosomal storage disorder caused by deficiency
of acid a-glucosidase and characterized by heart failure and skeletal muscle
weakness.
The experimental work described in this thesis was performed to elucidate
the cause of clinical heterogeneity in this disease and to test the feasibility of
receptor mediated enzyme replacement therapy
